Literature DB >> 12614936

Pathological and virological assessment of acute HTLV-I-associated myelopathy complicated with encephalopathy and systemic inflammation.

Marzia Puccioni-Sohler1, Leila Chimelli, Monica Merçon, Reizer R Gonçalves, Glicinia Pimenta, Celso Bianco, Maria Rios, Steven Jacobson.   

Abstract

HTLV-I-associated myelopathy, also known as tropical spastic paraparesis (HAM/TSP), is a chronic inflammatory disease of the spinal cord. Acute cases are uncommon. We report the case of a 41-year-old woman with acute HAM/TSP complicated with encephalitis, an intense inflammatory reaction of the nervous system and lymphocytic infiltration of skeletal muscles, liver, salivary, adrenal and pituitary glands. The immunohistochemical studies of the lymphocytes surrounding blood vessels showed both B- and T-lymphocytes, in similar proportion, with both CD4- and CD8-positive cells. In addition, many perivascular and scattered macrophages were observed. Adult T-cell leukemia/lymphoma (ATL) was ruled out. The marrow aspirate was normal. Serial cerebrospinal fluid (CSF) analysis showed presence of HTLV-I antibodies, but without intrathecal synthesis of specific antibodies. Determination of HTLV-I viral loads demonstrated increased levels in the CSF relative to the peripheral blood and may be associated with widespread inflammation. The pathological and immunological findings may help understand the role of immune-reactive cells in the pathogenesis of HTLV-I-associated myelopathy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12614936     DOI: 10.1016/s0022-510x(02)00413-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  The NK cell as a new player in the pathogenesis of HTLV-I associated neurologic disease.

Authors:  Steven Jacobson
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

2.  Accumulation of human T-lymphotropic virus type I (HTLV-I)-infected cells in the cerebrospinal fluid during the exacerbation of HTLV-I-associated myelopathy.

Authors:  Daisuke Hayashi; Ryuji Kubota; Norihiro Takenouchi; Tomonori Nakamura; Fujio Umehara; Kimiyoshi Arimura; Shuji Izumo; Mitsuhiro Osame
Journal:  J Neurovirol       Date:  2008-11-12       Impact factor: 2.643

3.  HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1).

Authors:  Stéphanie Olière; Eduardo Hernandez; Agnès Lézin; Meztli Arguello; Renée Douville; Thi Lien-Anh Nguyen; Stéphane Olindo; Gérard Panelatti; Mirdad Kazanji; Peter Wilkinson; Rafick-Pierre Sékaly; Raymond Césaire; John Hiscott
Journal:  PLoS Pathog       Date:  2010-11-04       Impact factor: 6.823

Review 4.  Human T-cell lymphotropic virus (HTLV)-associated encephalopathy: an under-recognised cause of acute encephalitis? Case series and literature review.

Authors:  Ania A Crawshaw; Divya Dhasmana; Brynmor Jones; Carolyn M Gabriel; Steve Sturman; Nicholas W S Davies; Graham P Taylor
Journal:  J Neurol       Date:  2018-02-08       Impact factor: 4.849

5.  Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Peter D Burbelo; Elise Meoli; Hannah P Leahy; Jhanelle Graham; Karen Yao; Unsong Oh; John E Janik; Renaud Mahieux; Fatah Kashanchi; Michael J Iadarola; Steven Jacobson
Journal:  Retrovirology       Date:  2008-10-20       Impact factor: 4.602

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.